Edwin Smith, MD
Pediatric Urology · Atlanta, GANPI 1003828179
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Boston Scientific at 26.5% of the total. Reporting peaked in 2022 at $437 and has fallen 80.2% since, to $86 in 2025.
Across 34 payments — averaging $32.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$294
- Teleflex LLC$164
- Bayer$109
- Endo Pharmaceuticals Inc.$77
- Novo Nordisk$69
- Axonics, Inc.$57
- plus $340 from 13 others
Across 1 payment — averaging $210.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$210
What the payments were for
- Food & beverage$1,104100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 5 | $294 |
| Teleflex LLC | 1 | $164 |
| Bayer | 5 | $109 |
| Endo Pharmaceuticals Inc. | 4 | $77 |
| Novo Nordisk | 2 | $69 |
| Axonics, Inc. | 2 | $57 |
| Angiodynamics, Inc. | 1 | $47 |
| Bracco Diagnostics Inc. | 1 | $43 |
| Merck | 2 | $42 |
| Johnson & Johnson | 1 | $29 |
| Coloplast | 1 | $27 |
| Novartis | 1 | $25 |
| Myovant Sciences Inc. | 1 | $25 |
| Progenics Pharmaceuticals, Inc. | 1 | $22 |
| Dendreon Pharmaceuticals LLC | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Blue Earth Diagnostics | 1 | $18 |
| Ambu Inc. | 1 | $16 |
| Travere Therapeutics, Inc. | 2 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$175
- Deflux$164
How this compares
Too few pediatric urology providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 49 | $573 |
Paid to pharmacies, not to this prescriber.
Other pediatric urology in Atlanta
- Andrew KirschAtlanta$320K
- Hal ScherzAtlanta$51K
- Emily BlumAtlanta$19K
- Michael Garcia-RoigAtlanta$5K
- Shuvro deAtlanta$4K
- James ElmoreAtlanta$2K
- Ricardo Arceo OlaizAtlanta$951
- Wolfgang CerwinkaAtlanta$315
- James PikeAugusta$7K
- Amanda RainesAugusta$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.